Cardiol Therapeutics Inc Share Price Today: Live Updates & Key Insights

Cardiol Therapeutics Inc share price today is $0.911, up -2.22%. The stock opened at $0.9501 against the previous close of $0.947, with an intraday high of $0.95335 and low of $0.9.

Cardiol Therapeutics Inc Share Price Chart

Cardiol Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Cardiol Therapeutics Inc Share Price Performance

$0.911 -0.0222(-2.22%) CRDL at 23 Mar 2026 12:33 PM Drug Manufacturers - Specialty & Generic
Lowest Today 0.9
Highest Today 0.95335
Today’s Open 0.9501
Prev. Close 0.947
52 Week High 1.59
52 Week Low 0.77
Day’s Range: Low 0.9 High 0.95335
52-Week Range: Low 0.77 High 1.59
1 day return -
1 Week return -12.12
1 month return -5.54
3 month return -7.77
6 month return -16.08
1 year return -16.08
3 year return +90.1
5 year return -61.66
10 year return -

Cardiol Therapeutics Inc Institutional Holdings

Tejara Capital Ltd 2.36

Global X Marijuana Life Sciences ETF 0.79

AdvisorShares Investments, LLC 0.54

Bank of America Corp 0.49

INTEGRITY ALLIANCE, LLC. 0.39

Two Sigma Investments LLC 0.36

The Goldman Sachs Group Inc 0.29

Mmcap International Inc. Spc 0.19

Susquehanna International Group, LLP 0.18

Morgan Stanley - Brokerage Accounts 0.14

Marshall Wace Asset Management Ltd 0.14

Virtu Financial LLC 0.13

Sheets Smith Investment Management 0.13

Summit Financial, LLC 0.09

1832 Asset Management L.P 0.09

Knoll Capital Management LP 0.09

We Are One Seven, LLC 0.09

UBS Group AG 0.05

Fidelity Nasdaq Composite Index 0.05

Geode Capital Management, LLC 0.05

QRG Capital Management, Inc. 0.04

Marble Harbor Investment Counsel, LLC 0.04

Ninepoint Alternative Health A 0.01

Ninepoint Cannabis & Alt Health S A 0.01

Blackstone Alternative Multi-Strategy I 0.00

Cardiol Therapeutics Inc Market Status

Strong Buy: 1

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

Cardiol Therapeutics Inc Fundamentals

Market Cap 103.42 M

PB Ratio 14.854

PE Ratio 0.0

Enterprise Value 96.55 M

Total Assets 31.86 M

Volume 638846

Cardiol Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:78760 0.1M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:78760 0.1M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-28006293 -28.0M, FY22:-30930647 -30.9M, FY21:-31638244 -31.6M, FY20:-20640935 -20.6M, FY19:-13684023 -13.7M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-61908 -0.1M

Quarterly Net worth Q3/2025:-9964281 -10.0M, Q2/2025:-8354371 -8.4M, Q1/2025:-8287653 -8.3M, Q3/2024:-12728484 -12.7M, Q2/2024:-6590873 -6.6M

About Cardiol Therapeutics Inc & investment objective

Company Information Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Organisation Drug Manufacturers - Specialty & Generic

Employees 18

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. David G. Elsley MBA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Cardiol Therapeutics Inc FAQs

What is the share price of Cardiol Therapeutics Inc today?

The current share price of Cardiol Therapeutics Inc is $0.911.

Can I buy Cardiol Therapeutics Inc shares in India?

Yes, Indian investors can buy Cardiol Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Cardiol Therapeutics Inc shares in India?

You can easily invest in Cardiol Therapeutics Inc shares from India by:

Can I buy fractional shares of Cardiol Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Cardiol Therapeutics Inc?

Cardiol Therapeutics Inc has a market cap of $103.42 M.

In which sector does Cardiol Therapeutics Inc belong?

Cardiol Therapeutics Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Cardiol Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Cardiol Therapeutics Inc?

The PE ratio of Cardiol Therapeutics Inc is N/A and the PB ratio is 14.85.